Preeclampsia research and new screening initiatives aim to reduce maternal mortality

New research and clinical developments are addressing preeclampsia, a dangerous pregnancy complication characterized by high blood pressure and potential organ damage. Affecting up to 8% of pregnant women globally, the condition contributes to approximately 16% of maternal deaths worldwide.

A study led by Flinders University and the University of Adelaide's Robinson Research Institute has identified clues regarding the causes of preeclampsia. Researchers are specifically investigating accelerated placental aging and the biological pathways that trigger it, aiming to find ways to protect both mothers and infants.

In clinical practice, the Dijon University Hospital (CHU) is launching a new prevention and screening pathway on November 1 to ensure the condition is no longer overlooked. While screening exists, Professor Emmanuel Simon noted that it is not yet covered by social security. Preeclampsia typically presents after the 20th week of pregnancy and is often asymptomatic, making early detection critical to preventing fatal outcomes.